Abstract
Hypoxia-inducible factor-1α (HIF-1α) is a critical regulatory protein of cellular response to hypoxia. In this study, we evaluated the relationship of HIF-1α with clinicopathologic parameters such as tumor stage and grade, as well as angiogenic profile and proliferation index. The immunoreactivity of HIF-1α was assessed in 70 cases of primary bladder urothelial carcinoma. Vascular endothelial growth factor (VEGF) and microvessel density (MVD) were used to evaluate the angiogenic profile. MVD was calculated by immunohistochemical staining of endothelial cells with CD34. Proliferation index was determined by the percentage of Ki-67 nuclear staining in tumor cells. There was a significant relationship between HIF-1α immunoreactivity and stage, as well as histologic grade of the tumor (P < 0.001). HIF-1α immunoreactivity was also closely related to VEGF expression (P < 0.001), MVD (P = 0.002) and proliferation index (P < 0.001). VEGF, MVD and proliferation index were found to be closely related to tumor stage and histologic grade. There was no correlation between HIF-1α immunoreactivity and lamina propria (P = 0.13), muscularis propria (P = 0.009) or vascular invasion (P = 0.1). In this study, HIF-1α expression was found to be closely related to prognostic parameters in bladder urothelial carcinoma. For this reason, it may be a useful marker to determine the prognosis and to choose the appropriate treatment modality.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Yamakawa M, Liu LX, Date T, Belanger AJ, Vincent KA, Akita GY et al (2003) Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors. Circ Res 93:664–673. doi:10.1161/01.RES.0000093984.48643.D7
Forsythe JA, Jiang B, Iyer NV, Agani F, Leung SW, Koos RD et al (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16:4604–4613
Schmid T, Zhou J, Brüne B (2004) HIF–1 and p53: communication of transcription factors under hypoxia. J Cell Mol 8(4):423–431. doi:10.1111/j.1582-4934.2004.tb00467.x
Bos R, Zhong H, Hanrahan FC, Mommers CM, Semenza GL, Pinedo HM et al (2001) Levels of hypoxia-ınducible factor–1α during breast carcinogenesis. J Natl Cancer Inst 93(4):309–314. doi:10.1093/jnci/93.4.309
Talks KL, Turley H, Gatter HC, Maxwell PH, Pugh CW, Ratcliffe PJ et al (2000) The expression and distrubition of hypoxia-inducible factors HIF–1α and HIF–2α in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol 157:411–421
Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D et al (1999) Overexpression of HIF-1α in common human cancers and their metastases. Cancer Res 59:5830–5835
Bos R, Zhong H, Hanrahan CF, Mommers ECM, Semenza GL, Pinedo HM et al (2001) Levels of hypoxia-inducible factor-1α during breast carcinogenesis. J Natl Cancer Inst 93:309–314. doi:10.1093/jnci/93.4.309
Bos R, van Diest PJ, de Jong JS, van der Groep P, van der Valk P, van der Wall E (2005) Hypoxia-inducible factor-1α is associated with angiogenesis and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer. Histopathology 46:31–36. doi:10.1111/j.1365-2559.2005.02045.x
Theodoropoulos VE, Lazaris AC, Sofras F, Gerzelis I, Tsoukala V, Ghikonti I et al (2004) Hypoxia inducible factor-1α expression correlates with angiogenesis and unfavorable prognosis in bladder cancer. Eur Urol 46:200–208. doi:10.1016/j.eururo.2004.04.008
Theodoropoulos VE, Lazaris AC, Kastriotis I, Spiliadi C, Theodoropoulos GE, Tsoukala V et al (2005) Evaluation of hypoxia-inducible factor 1α overexpression as a predictor of tumor recurrence and progression in superficial urothelial bladder carcinoma. BJU Int 95:425–431. doi:10.1111/j.1464-410X.2005.05314.x
Eltz S, Comperat E, Cussenot O, Roupret M (2008) Molecular and histological markers in urothelial carcinomas of the upper urinary tract. BJU Int 102(5):532–535. doi:10.1111/j.1464-410X.2008.07659.x
Chai CY, Chen WT, Hung WC, Kang WY, Huang YC, Su YC et al (2008) Hypoxia-inducible factor-1alpha expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma. J Clin Pathol 61(5):658–664. doi:10.1136/jcp.2007.050666
Popov Z, Gil-Dilez-De-Medina S, Ravery V, Hoznek A, Bastuji-Garin S, Lefrere-Belda MA et al (2004) Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications. Urol Oncol 22(2):93–101. doi:10.1016/j.urolonc.2004.01.001
Rodriguez-Alonso A, Pita-Fernandez S, Gonzales-Carrero J, Nogueira-March JL (2002) P53 and Ki–67 expression as prognostic factors for cancer-related survival in stage T1 transitional cell bladder carcinoma. Eur Urol 41(2):182–188. doi:10.1016/S0302-2838(01)00038-0
Kruger S, Muller H (1995) Correlation of morphometry, nucleolar organizer regions, proliferating cell nuclear antigen and Ki67 antigen expression with grading and staging in urinary bladder carcinomas. Br J Urol 75(4):480–484. doi:10.1111/j.1464-410X.1995.tb07269.x
Jones A, Fujiyama C, Blanche C, Moore JW, Fuggle S, Cranston D et al (2001) Relation of VEGF production to expression and regulation of hypoxia-inducible factor–1α and hypoxia-inducible factor–2α in human bladder tumors and cell lines. Clin Cancer Res 7:1263–1272
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Deniz, H., Karakök, M., Yagcı, F. et al. Evaluation of relationship between HIF-1α immunoreactivity and stage, grade, angiogenic profile and proliferative index in bladder urothelial carcinomas. Int Urol Nephrol 42, 103–107 (2010). https://doi.org/10.1007/s11255-009-9590-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-009-9590-5